Independent · Evidence-led · We don't sell peptides
EU / NordicsUpdated weeklyEN

Explore this article's sources with AI

ChatGPTClaudePerplexityGeminiGrokGoogle AI

Follow PeptideMethods on Google

First published

Semaglutide import rules in Denmark

Denmark permits some personal semaglutide imports, but lawful sale, exact product identity and personal-use records still matter.

Why we wrote this. Danish readers need the 2026 import rule separated into carriage, postal delivery, pharmacy verification and product-level checks.

In this article (8 sections)
  1. The rule changed on 1 January 2026
  2. Personal carriage and postal delivery are separate fact patterns
  3. Lawful semaglutide starts with the exact product
  4. How to check a foreign online pharmacy
  5. What customs and other authorities may need to establish
  6. The grey-market reality
  7. A practical verification sequence
  8. Bottom line

Yes, a private individual can in principle bring or receive an authorised semaglutide medicine in Denmark for personal use. Since 1 January 2026, the Danish rule covers regular medicine from EU or EEA countries and from countries outside that area. The medicine must have been legally purchased in the country of sale, and the individual must be able to show that it is for personal use[1][2].

That is a conditional route, not permission to order any item labelled semaglutide. The test changes with the exact product, seller, prescription and method of entry. An authorised Ozempic or Wegovy pack dispensed by a lawful pharmacy is different from an unbranded vial, compounded preparation, copied pen or research powder that cannot be matched to an official medicine record.

The rule changed on 1 January 2026

The Danish Medicines Agency says individuals may now import medicine for personal use from any country, subject to the legal-sale condition and exceptions for antibiotics, narcotic substances and doping agents[2]. The agency's detailed guidance applies the rule both when a traveller enters Denmark carrying medicine and when medicine arrives by mail[1].

Executive Order no. 1523 of 3 December 2025 is the legal instrument on private individuals importing medicines for humans and animals[3]. It establishes the 2026 framework. The agency's guidance is the more practical starting point, but the order matters when the facts do not fit a simple example.

The change widened the geography for ordinary private imports. It did not turn prescription medicines into over-the-counter products, approve a new semaglutide formulation or make every online sale legal. The source country still decides whether the seller could lawfully supply the exact medicine there, while the Danish rule asks whether the resulting import meets the personal-use conditions.

Personal carriage and postal delivery are separate fact patterns

Personal carriage means the individual enters Denmark with the medicine in their luggage or otherwise accompanies it across the border. The official guidance permits this for medicine legally purchased abroad for personal use. A matching prescription, receipt, pharmacy label and original packaging can help connect the pack to the traveller and transaction. None of those documents should be altered or borrowed from another person.

Postal or courier import means the medicine is sent to Denmark without the buyer carrying it. The same core tests remain: lawful sale in the country of purchase and personal use. Delivery by a familiar courier does not prove that the seller is licensed, that a prescription was valid or that the parcel contains an authorised finished medicine.

These routes should not be collapsed into a quantity rule. The Danish page gives prescription or receipt as examples of personal-use documentation, but it does not publish a semaglutide pack count that guarantees release. Quantity can be relevant to whether an order looks personal, yet product identity and lawful sale cannot be replaced by choosing a smaller parcel.

Lawful semaglutide starts with the exact product

EMA lists Ozempic as an authorised EU medicine containing semaglutide for type 2 diabetes, and states that it can only be obtained with a prescription[5]. EMA separately lists Wegovy as an authorised semaglutide medicine for weight management in defined groups and also places it within a prescription framework[6]. These are separate products with their own indications, presentations and product information.

A lawful import analysis therefore begins with the brand, strength, dosage form, manufacturer, pack and authorisation details. It then checks the dispensing seller and prescription. The word semaglutide on a vial is not enough. A product cannot borrow Ozempic's or Wegovy's EU authorisation merely because it claims to contain the same active ingredient.

Product indication and import permission also answer different questions. An authorised indication describes when the medicine may be used under its product information. It does not guarantee that a foreign pharmacy can dispense to a particular buyer, that a Danish prescription will be accepted abroad or that every pack advertised under that brand is genuine.

How to check a foreign online pharmacy

The Danish Medicines Agency tells consumers to look for the common EU logo when buying human medicines online in the EU. The green logo should link to the relevant national authority's register, where the online shop's name and web address can be checked[4]. A copied logo image is not verification. The regulator entry reached through the logo is the useful evidence.

A pharmacy listing is necessary evidence for many online routes, but it does not settle the whole transaction. Confirm that the registered web address is exact, that the pharmacy is allowed to sell the particular prescription medicine, and that it follows the source country's prescription rules. A site offering Ozempic or Wegovy without the documentation its own jurisdiction requires is not made lawful by shipping to Denmark.

For a seller outside the EU or EEA, there may be no EU logo. Use the source-country regulator's pharmacy register and medicine database instead. Check the exact finished product and seller separately. A foreign approval claim, telehealth consultation or invoice should be verified against the regulator's own records rather than accepted from the seller's page.

What customs and other authorities may need to establish

The Danish Medicines Agency says it stopped routine checks of private medicine imports when the 2026 rules took effect. That does not repeal the conditions or promise that a medicine parcel will never be examined. Customs, police or medicine authorities may still become involved where a declaration, product, seller or restricted category creates a separate concern.

There is no official semaglutide checklist that guarantees customs clearance. The facts closest to the published import test are the exact product, country and seller, evidence that the medicine was legally sold, the prescription and receipt, and evidence that it is for the recipient's own use. Sender details, packaging, quantity and the parcel declaration may help officials understand those facts, but no single item cures an unlawful sale or unidentified product.

Customs treatment and medicine legality are not the same decision. Payment of tax, duty or a courier handling fee does not prove that a prescription medicine may lawfully be supplied. Conversely, a medicine-law question cannot be answered only by calculating import charges. Readers should follow the authority and case reference shown on any notice rather than assume which agency is deciding the matter.

If a parcel is held, describe the contents accurately and provide unaltered product, prescription and purchase records when requested. Do not ask a seller to relabel a medicine as a supplement, sample or gift. A parcel arriving without intervention is not an approval decision and does not establish that the pen or vial is genuine.

The grey-market reality

Grey-market sites commonly advertise semaglutide vials, powders or pens outside an identifiable pharmacy route. Some use a research-use disclaimer; others present a certificate of analysis. Those materials do not show that the offered item is an authorised Ozempic or Wegovy pack, that the seller may dispense prescription medicine, or that the shipped unit matches any tested sample.

The supply risks are not limited to ingredient identity. An online offer may provide no defensible evidence of sterile manufacture, correct concentration, dose delivery, storage or cold-chain control. Brand-like packaging can also be copied. Official product information for authorised semaglutide medicines cannot be transferred to an unverified product just because the same ingredient name appears on its label.

We do not list vendors, rank shipping origins or describe declaration tactics. Those details cannot establish lawful sale and could encourage evasion. The useful questions are whether the exact medicine is authorised, whether the seller is licensed, whether the prescription process is lawful, and whether the Danish personal-use rule applies to the actual transaction.

A practical verification sequence

First, match the offered pack to an official regulator record. Record its name, strength, form, manufacturer and authorisation number. Second, verify the seller on the source-country pharmacy register. Third, confirm the prescription and dispensing requirements with that regulator or pharmacy. Fourth, retain the prescription, invoice and pharmacy details so they all identify the same recipient and product.

For personal carriage, keep the medicine with its original pharmacy label and supporting records. For postal or courier delivery, also verify the sender's registered identity and make sure the parcel description is accurate. An offer that is a raw powder, research vial or product that cannot be matched to an official authorisation should not be treated as equivalent to Ozempic or Wegovy.

For medicine background, see the semaglutide overview and its semaglutide regulation section. The Denmark regulation hub covers the wider national framework. None can pre-clear a particular parcel without the product and transaction records.

Bottom line

An authorised semaglutide medicine may fit Denmark's personal-import rule when it was sold legally in the source country, is for the recipient's own use and is supported by matching prescription and purchase records. This applies in principle to personal carriage and mail or courier delivery. The 2026 change makes geography less restrictive, but it leaves lawful sale and product identity at the centre.

An unidentified semaglutide vial does not gain Ozempic's or Wegovy's status through a personal-use statement. If the product, pharmacy or prescription route cannot be verified in official records, import eligibility should not be assumed. Ask the Danish Medicines Agency about the medicine rule, the relevant source-country regulator about the seller, and a Danish lawyer if an official decision is disputed.

Medical disclaimer: This article is for educational and journalistic purposes only and does not constitute medical advice. Peptides discussed may be classified as prescription medicines or research chemicals depending on your jurisdiction. Always consult a qualified healthcare professional before using any peptide product. PeptideMethods.com does not sell, distribute, or facilitate the sale of any peptide product.

Regulatory disclaimer: This page reflects our understanding of the regulatory status as of 2026-11-05. Regulations change. Verify with the official regulator before making any decision. PeptideMethods.com is not a law firm and does not provide legal advice.

Frequently asked

Can I bring semaglutide into Denmark in my luggage?

Potentially. The exact medicine must have been legally purchased abroad and be for your personal use. Keep matching prescription, receipt, pharmacy label and original packaging, and check that the product is an authorised medicine.

Can semaglutide be mailed or couriered to Denmark?

Denmark's 2026 guidance permits regular medicine by mail from EU or EEA and non-EU or EEA countries when the sale was legal and the medicine is for personal use. Delivery does not validate an unidentified product or unlicensed seller.

Does a prescription make any semaglutide import legal?

No. A prescription can support personal use and lawful dispensing, but the exact product and seller must still be legitimate under the source country's rules. It cannot authenticate an unbranded vial.

How do I verify an EU online pharmacy selling semaglutide?

Use the green EU logo on the pharmacy site and follow it to the national regulator's register. Confirm that the exact shop name and web address appear there, then check the product and prescription process separately.

What should I do if a semaglutide parcel is held?

Use the case reference and authority named in the official notice. Describe the contents accurately and provide unaltered product, prescription and purchase records. Ask a Danish lawyer for advice if the decision is disputed.

Sources

  1. [1]Danish Medicines Agency: how to import medicine into Denmark from 1 January 2026Tier 1 · primary↩
  2. [2]Danish Medicines Agency: new personal medicine import rules from 1 January 2026Tier 1 · primary↩
  3. [3]Danish Executive Order no. 1523 of 3 December 2025 on private medicine importsTier 1 · primary↩
  4. [4]Danish Medicines Agency: buying and selling medicines onlineTier 1 · primary↩
  5. [5]European Medicines Agency: Ozempic EU authorisation and product informationTier 1 · primary↩
  6. [6]European Medicines Agency: Wegovy EU authorisation and product informationTier 1 · primary↩

No revisions yet. First published .

About the editorial team

PeptideMethods is written and edited by the PeptideMethods Editorial Team and published by Digital Compass Group Ltd. The team is not made up of medical professionals; every health, regulatory or dosage claim on the site is tied to a primary source and is not a substitute for advice from a qualified clinician.

See our editorial policy and methodology for how we research, source and verify.

Read the pillars